Jelaskan Penelitian dari Agen hipolipidemia

Kelas investigasi agen hipolipidemik :

CETP inhibitor (transfer protein cholesteryl ester), 1 kandidat sedang dalam uji coba. Diharapkan bahwa obat-obatan ini terutama akan meningkatkan HDL sambil menurunkan LDL Squalene synthase inhibitor ApoA-1 Milano succinobucol (AGI-1067), antioksidan baru, gagal dalam percobaan fase-III. Apoprotein-B inhibitor mipomersen (disetujui oleh FDA pada 2013 hiperkolesterolemia keluarga homozigot.). Bempedoic acid, sebuah ATP citrate lyase inhibitor

Alenghat, Francis J. ; Davis, Andrew M. (2019). "Management of Blood Cholesterol". JAMA. 321: 800. doi:10. 1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.

AMDA - The Society for Post-Acute and Long-Term Care Medicine (February 2014). "Ten Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, AMDA - The Society for Post-Acute and Long Term Care Medicine, retrieved 20 April 2015.

Wojcicki, J.; Pawlik, A.; Samochowiec, L.; Kaldo??Ska, M.; Mysliwiec, Z. (1995). "Phytotherapy Research. 9 (8): 597-599. doit:10. 1002/ptr.2650090814.

"Omega-3 Supplements: In Depth". NCCIH. 2009-07-01. Retrieved 2019-08-12.

Koren MJ, Scott R, Kim JB et al Lancet 2012; 380:1995-2006

Gugliano RP, Desain Nr, Kohli P et al Lancet 2012; 380:2007-17

Pollack, Andrew (29 January 2013) F.D.A. Approves Genetic Drug to Treat Rare Disease The New York Times, Retrieved 31 January 2013

Staff (29 January 2013) FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder U.S. Foof and Drug Administration, Retrieved 31 January 2013